Application of a Novel Murine Model of Mucopolysaccharidosis Type II for Developing Human Hematopoietic Stem Cell Gene Therapy

被引：0
|
作者：
Shimada, Yohta [1 ]
Ishii, Natsumi [1 ]
Higuchi, Takashi [1 ]
Goto, Motohito [2 ]
Ohashi, Toya [3 ]
Kobayashi, Hiroshi [1 ]
机构：
[1] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Gene Therapy, Tokyo, Japan
[2] Cent Inst Expt Anim CIEA, Anim Resource Technol Ctr, Kawasaki, Kanagawa, Japan
[3] Jikei Univ, Sch Nursing, Dept Human Hlth Sci & Therapeut, Tokyo, Japan
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
234
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [41] Novel Approaches and Mechanisms in Hematopoietic Stem Cell Gene Therapy
    Bigger, Brian W.
    Wynn, Robert F.
    DISCOVERY MEDICINE, 2014, 17 (94) : 207 - 215
  • [42] Brain targeted stem cell gene therapy provides long-term correction of mucopolysaccharidosis type II
    Bigger, Brian
    Liao, Ai-Yin
    Gleitz, Helene
    Holley, Rebecca
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S31 - S32
  • [43] Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms
    Gleitz, Helene F. E.
    Liao, Ai Yin
    Cook, James R.
    Rowlston, Samuel F.
    Forte, Gabriella M. A.
    D'Souza, Zelpha
    O'Leary, Claire
    Holley, Rebecca J.
    Bigger, Brian W.
    EMBO MOLECULAR MEDICINE, 2018, 10 (07)
  • [44] Brain targeted stem cell gene therapy provides long-term correction of mucopolysaccharidosis type II
    Wood, S. R.
    Liao, A. Y.
    Gleitz, H. F.
    Forte, G. M.
    Taylor, J. T.
    O'Leary, C.
    Holley, R. J.
    Bigger, B. W.
    HUMAN GENE THERAPY, 2019, 30 (08) : A31 - A31
  • [45] Neurodevelopmental outcomes of hematopoietic stem cell transplantation for mucopolysaccharidosis type II: A prospective, longitudinal study
    Bascou, Nicholas A.
    Kiely, Bridget
    Safonova, Aleksandra
    Beltran, Maria L.
    Poe, Michele D.
    Szabolcs, Paul
    Escolar, Maria L.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S27 - S27
  • [46] Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice
    Langford-Smith, Alexander
    Wilkinson, Fiona L.
    Langford-Smith, Kia J.
    Holley, Rebecca J.
    Sergijenko, Ana
    Howe, Steven J.
    Bennett, William R.
    Jones, Simon A.
    Wraith, J. E.
    Merry, Catherine L. R.
    Wynn, Robert F.
    Bigger, Brian W.
    MOLECULAR THERAPY, 2012, 20 (08) : 1610 - 1621
  • [47] Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II
    Yamazaki, Narutoshi
    Ohira, Mari
    Takada, Shuji
    Ohtake, Akira
    Onodera, Masafumi
    Nakanishi, Mahito
    Okuyama, Torayuki
    Mashima, Ryuichi
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2023, 37
  • [48] Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II
    Yamazaki, Narutoshi
    Mashima, Ryuichi
    Okuyama, Torayuki
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S129 - S129
  • [49] Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector
    Di Domenico, C
    Villani, GRD
    Di Napoli, D
    Reyero, EGY
    Lombardo, A
    Naldini, L
    Di Natale, P
    HUMAN GENE THERAPY, 2005, 16 (01) : 81 - 90
  • [50] Lentiviral mediated gene therapy for murine mucopolysaccharidosis type IIIA
    McIntyre, Chantelle
    Roberts, Ainslie
    Ranieri, Enzo
    Clements, Peter R.
    Byers, Sharon
    Anson, Donald S.
    JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 531 - 531
12345